Article

Maker of Pain-Relieving Copper Clothing Slammed with $1.35 Million Settlement

If copper clothing is on your list of options to treat chronic pain, you might want to rethink that one.

If copper clothing is on your list of options to treat chronic pain, you might want to rethink that one.

Tommie Copper Inc. is in big trouble with the Federal Trade Commission (FTC) for claiming that its copper clothing can relieve the pain associated with multiple conditions, including arthritis, fibromyalgia, and multiple sclerosis. The company is based in Mount Kisco, New York.

“It’s tempting to believe that wearing certain clothing will eliminate severe pain, but Tommie Copper didn’t have science to back its claims,” Jessica Rich, director of the FTC’s Bureau of Consumer Protection, said in a news release.

The company sells shirts, socks, braces, and sleeves that range from $29.95 to $69.50. According to the FTC complaint, Tommie Copper claimed that their garments could alleviated pain comparable or better than drugs or surgery — a declaration that the FTC says is false or unsubstantiated. From April 2011 to October 2014, the company generated around $87 million.

  • MD Magazine’s Pain Management specialty page

Television personality, Montel Williams, starred in the company’s infomercials saying, “This can give your life back… Period.” He even went on to say that the garments worked to relieve his multiple sclerosis-associated pain. However, the FTC is saying that Tommie Copper produced false advertisements.

The company is ordered to pay $1.35 million — which could jump to $86.8 million if the federal court declares that the defendants misrepresented the financial condition.

The unanimous Commission vote (4 to 0) authorized the complaint’s approval and has been proposed to the US District Court for the Southern District of New York.

“If you see an ad for a product that promises to replace the need for drugs or surgery, talk to a healthcare professional before you spend your money,” Rich warned.

What to Read Next >>> Fibromyalgia Drug Moves to Next Phase to Improve Pain and Sleep Quality

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.